The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ACADIA PHARMACEUTICALS INC COM 004225108   24,097,835 769,653 SH   SOLE   769,653 0 0
AMICUS THERAPEUTICS INC COM 03152W109   21,129,265 1,489,025 SH   SOLE   1,489,025 0 0
ARVINAS INC COM 04335A105   20,773,452 504,700 SH   SOLE   504,700 0 0
ASCENDIS PHARMA A/S SPONSORED ADR 04351P101   20,627,083 163,772 SH   SOLE   163,772 0 0
CHURCHILL CAPITAL CORP VII *W EXP 02/29/202 17144M110   71,295 548,000 SH   SOLE   548,000 0 0
COMPASS DIGITAL ACQUISITION CORP *W EXP 09/29/202 G2476C123   22,259 459,906 SH   SOLE   459,906 0 0
CONCORD ACQUISITION CORP II *W EXP 99/99/999 20607U116   53,083 408,333 SH   SOLE   408,333 0 0
CYTOKINETICS INC COM NEW 23282W605   36,042,049 431,693 SH   SOLE   431,693 0 0
CALIDI BIOTHERAPEUTICS INC COM NEW 320703101   188,750 125,000 SH   SOLE   125,000 0 0
CALIDI BIOTHERAPEUTICS INC *W EXP 03/14/202 320703119   32,760 655,200 SH   SOLE   655,200 0 0
GALAPAGOS NV SPON ADR 36315X101   18,644,488 458,659 SH   SOLE   458,659 0 0
HOME PLATE ACQUISITION CORP *W EXP 09/30/202 43734R111   20,014,212 331,416 SH   SOLE   331,416 0 0
LIBERTY BROADBAND CORP COM SER C 530307305   14,865,631 184,460 SH   SOLE   184,460 0 0
MARBLEGATE ACQUISITION CORP *W EXP 08/31/202 56608A113   22,050 735,000 SH   SOLE   735,000 0 0
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD 61559X104   62,740 895,000 SH   SOLE   895,000 0 0
MORPHIC HOLDING INC COM 61775R105   14,349,201 496,856 SH   SOLE   496,856 0 0
PROTHENA CORP PLC SHS G72800108   12,693,562 349,300 SH   SOLE   349,300 0 0
RELAY THERAPEUTICS INC COM 75943R102   14,509,749 1,317,870 SH   SOLE   1,317,870 0 0
REVOLUTION MEDICINES INC COM 76155X100   17,698,428 617,100 SH   SOLE   617,100 0 0
ROSS ACQUISITION CORP II *W EXP 02/01/202 G7641C114   24,621 439,666 SH   SOLE   439,666 0 0
SAREPTA THERAPEUTICS INC COM 803607100   14,016,776 145,357 SH   SOLE   145,357 0 0
SOLID BIOSCIENCES INC COM NEW 83422E204   5,902,081 961,251 SH   SOLE   961,251 0 0
SPIRIT AIRLINES INC COM 848577102   27,863,000 1,700,000 SH Call SOLE   1,700,000 0 0
SPRINGWORKS THERAPEUTICS INC COM 85205L107   20,327,872 556,928 SH   SOLE   556,928 0 0
SWIFTMERGE ACQUISITION CORP *W EXP 12/13/202 G63836111   20,090 490,000 SH   SOLE   490,000 0 0
TRAVERE THERAPEUTICS INC COM 89422G107   12,903,536 1,435,321 SH   SOLE   1,435,321 0 0
YS BIOPHARMA CO LTD *W EXP 03/15/202 G9845F117   13,279 489,999 SH   SOLE   489,999 0 0